NAD project won the Second prize award in the section “Best Completed Project Contest”
during the award ceremony that took place at Conference Dinner of Industrial Technologies 2014 Conference 2014 on April 10th, 2014
The prize was given to Massimo Masserini, coordinator of NAD project, by Clara de la Torre,
Director responsible for "Research and Innovation" in the European Commission
The success story about NAD project is online on the H2020 website
The NAD project is also mentioned in the brochure that President Barroso sent to the Heads of Government, in advance of European Council Summit
See brochure: Horizon 2020: boosting industrial competitiveness with NAD on page 5.
The NAD (Nanoparticles for therapy and diagnosis of Alzheimer's disease) Project is aiming to
develop nanoparticles for Alzheimer's diagnosis and therapy.
Recent statistics estimate that 24.3 million people have dementia today, with 4.6 million new cases of dementia
every year (one new case every 7 seconds). In the EU, about 5 million people have dementia,with Alzheimer’s
disease (AD) accounting for over 3 million.
The goal of the study, developed in the field of nanotechnologies, is to create nanoparticles (NPs)able
to cross the blood-brain barrier to reach the brain, principal site of Alzheimer's disease. Molecules that
can recognize (diagnosis) and destroy (therapy) the amyloid deposits, characteristic of the illness, will be
attached to the nanoparticles, and tested on animal models of the disease (transgenic mice). If the
expectations of the research are attained, future experiments can be performed on humans.
The results can have an enormous impact on the early diagnosis and therapy of a disease of high
incidence, which takes a heavy social cost.
The NAD project involves 19 European research centers of 13 European countries (Italy,France,
Slovakia, Sweden, Netherlands, Hungary, Finland, Greece, Belgium, Spain, United Kingdom, Portugal,
Research area: NMP-2007-4.0-4 Substantial innovation in the European medical industry:
development of nanotechnology-based systems for in-vivo diagnosis and therapy
(in coordination with topic HEALTH-2007-2.4.1-7 and HEALTH-2007-1.2-3 in Theme 1 "Health")
Prof. Masserini of University of Milano-Bicocca is the scientific coordinator of the project.